Search terms
Singapore – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of the Azurion with FlexArm in ASEAN Pacific in May 2019 at the Philips APAC Center. This revolutionary solution establishes a new standard for patient imaging and positioning flexibility for image-guided procedures.
With a rising demand for complex interventions, metric-driven outcomes, and cost-efficiency care delivery, clinicians now face the challenge to find the right tools that enable them to continue providing superior care to patients. In Asia, chronic conditions such as cardiovascular diseases, coupled with an aging population, are driving the need for more minimally invasive procedures. By 2030, Asia is expected to be home to over 60% of the total population aged 65 years or older.i This phenomenon resulted in a strong appeal for minimally invasive surgeries for patients, with the aim to improve outcomes at lower risks and cost.
Ushering in the new Azurion with FlexArm, this advanced ceiling-mounted system provides expanded imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams. With Azurion with FlexArm’s small footprint, the system is particularly beneficial for Asian labs as they are generally smaller compared to the West. With Azurion with FlexArm, clinicians can quickly and easily visualizes critical details of the anatomy and identify changes to the patient during procedures. Its full set of innovations also enables clinicians to perform 2D and 3D imaging across the whole patient. As the clinician moves the system, the image beam automatically maintains alignment with the patient, allowing consistent visualization without having to move the patient or pivot the table. This can enhance overall patient experience and quality of care, while promoting efficiency.
“Philips’ engineers have overcome extremely challenging geometric and mechanical barriers to create Azurion with FlexArm. The system enables us to dramatically optimize procedures around the patient, where we can now capture optimal views of the patient, without encumbering all the clinicians who are working around the table. The new system is not only easy and intuitive to use, but its intelligent pivoting movement allows it to free up space around the table for clinicians to work in the most ergonomic position. In the heat of complex procedures, we can already see how the genius of this innovation delivers better clinical outcomes and long-term economic value for a more diverse range of procedure,” said Shannon Thomas, MD, Prince of Wales Public and Private Hospital, Australia.
Empowered by a unique smart kinematic engine, the system moves on eight different axes, controlled with a single ‘Axsys’ controller. Simulation tests with clinicians have demonstrated the system’s potential to significantly reduce the repositioning of the patient, staff and equipment to improve access for minimally invasive procedures, such as radial access, and to reduce the risk of unintentional pulling of wires and tubes, as well as significant time savings.ii The system is suited for Hybrid ORs that cater to multiple specialties in one room, such as a combination of surgical and endovascular procedures.
Two years since its launch, Azurion is now established as the leading platform for interventional procedures, favored by clinicians for its intuitive, seamless approach, and by hospital administrators for its positive impact on productivity and efficiency,
Ronald Tabaksblat
Business Leader Image Guided Therapy Systems, Philips
Azurion with FlexArm is the latest innovation in Philips’ unique portfolio of systems, smart devices, software and services in image-guided therapy, combined to provide healthcare providers with sophisticated, procedure-oriented solutions.
Since its global launch in February 2017, over half a million patients have been treated in more than 80 countries using a Philips Azurion system. The Philips Azurion 7 C20 with FlexArm is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration.
“This article is intended for healthcare professionals only. The content may contain references to specific Philips products and services that may not be (readily) available in a particular country outside of Australia and Thailand. Any such reference does not imply or warrant that any such products or services shall be available at any time in any particular country. Please contact your local Philips business contact for further information.”
i Deloitte Insights. Voice of Asia Report. Third Edition, September 2017
iiUselab simulation test with 17 clinicians
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Read MoreRead Less
August 01, 2019
June 17, 2019
June 17, 2019
June 10, 2019
May 02, 2019
March 27, 2019
